StocksDeepDive
Snapshot · Russell 3000 · generated 2026-09-19 21:53 UTC

TARS — Tarsus Pharmaceuticals, Inc.

FAIR (MOS +2.0%) · Quality 55/100

Price
78.09
Intrinsic value
79.68
Margin of safety
+2.0%
Implied growth (reverse DCF)
+15.7%
model assumes +16.0%
Value Score
21.4
Quality
55
Psychology
-13.1
Discovery
8.6
price/volume attention only
Moat score
20
erosion: none

Value Score: bottom 33% of Russell 3000 · Quality: top 46%

Open the interactive Deep Dive for TARS →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/TARS - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is TARS undervalued?

As of 2026-09-19, TARS trades at 78.09 against a computed intrinsic value of 79.68 (+2.0% margin of safety) - StocksDeepDive's valuation label for this is FAIR. This is a described calculation from public data, not a recommendation.

What is Tarsus Pharmaceuticals, Inc.'s Value Score?

Tarsus Pharmaceuticals, Inc.'s Value Score is 21.4 as of 2026-09-19 - it combines value, quality, crowd psychology and market attention into one number.